Opioid Induced Constipation Drugs Market 2027 By Drug Type, Prescription Type, Impact of covid-19 pandemic. | The Insight Partners

Opioid Induced Constipation Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Naldemedine, Docusate Sodium, Others); Prescription Type (Prescribed Drugs, Over the Counter Drugs), Impact of covid-19 pandemic.

Report Code: TIPRE00017476 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Opioid drugs are known to inhibit gastric emptying and peristalsis in the GI tract which results in delayed absorption of medications and increased absorption of fluid. The lack of fluid in the intestine leads to hardening of stool and constipation. Most patients with OIC complain of straining and incomplete emptying of the rectum during defecation. Opioids also increase anal sphincter tone impairing the defecation reflex. Anal sphincter dysfunction is important to note in patients experiencing anal blockage. Moreover, opioids have been found to decrease emptying of pancreatic juice and bile leading to delayed digestion. Opioid-induced constipation (OIC) accounts for more than 40% to 60% of noncancerous patients receiving opioids.

MARKET DYNAMICS

Opioid Induced Constipation Drugs market is driving due to factors such as alarming growth in opioid prescription for non-cancer pain and increasing prevalence of opioid induced constipation. However, factors such as, lack of awareness about OIC among the patients and rising preference for general laxatives and ongoing research activities to develop next-generation analgesics to replace opioids is expected to hamper the market growth.

MARKET SCOPE

The Opioid Induced Constipation Drugs market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Opioid Induced Constipation Drugs market with detailed market segmentation by drug type and prescription type. The Opioid Induced Constipation Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Opioid Induced Constipation Drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Opioid Induced Constipation Drugs market is segmented on the basis of drug type and prescription type. Based on drug type, the market is segmented as Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Naldemedine, Docusate Sodium, Others. Based on prescription type, market is segmented as prescribed drugs, over the counter drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Opioid Induced Constipation Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Induced Constipation Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Opioid Induced Constipation Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Induced Constipation Drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Opioid Induced Constipation Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Opioid Induced Constipation Drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Opioid Induced Constipation Drugs in the global market. Below mentioned is the list of few companies engaged in the Opioid Induced Constipation Drugs market.
The report also includes the profiles of key players in Opioid Induced Constipation Drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AstraZeneca plc.
  •  Mallinckrodt Pharmaceuticals
  •  Salix Pharmaceuticals Inc.
  •  Merck & Co Inc.
  •  Shionogi & Co Ltd.
  •  Ironwood Pharmaceutical Inc.
  •  Pfizer
  •  Progenics Pharmaceuticals Inc.
  •  Nektar Therapeutics
  •  Purdue Pharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Opioid Induced Constipation Drugs Market - By Drug Type
1.3.2 Opioid Induced Constipation Drugs Market - By Prescription Type
1.3.3 Opioid Induced Constipation Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OPIOID INDUCED CONSTIPATION DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OPIOID INDUCED CONSTIPATION DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. OPIOID INDUCED CONSTIPATION DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OPIOID INDUCED CONSTIPATION DRUGS - GLOBAL MARKET OVERVIEW
6.2. OPIOID INDUCED CONSTIPATION DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OPIOID INDUCED CONSTIPATION DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. METHYLNALTREXONE BROMIDE
7.3.1. Overview
7.3.2. Methylnaltrexone Bromide Market Forecast and Analysis
7.4. LUBIPROSTONE
7.4.1. Overview
7.4.2. Lubiprostone Market Forecast and Analysis
7.5. NALOXEGOL
7.5.1. Overview
7.5.2. Naloxegol Market Forecast and Analysis
7.6. NALDEMEDINE
7.6.1. Overview
7.6.2. Naldemedine Market Forecast and Analysis
7.7. DOCUSATE SODIUM
7.7.1. Overview
7.7.2. Docusate Sodium Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. OPIOID INDUCED CONSTIPATION DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRESCRIPTION TYPE
8.1. OVERVIEW
8.2. PRESCRIPTION TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIBED DRUGS
8.3.1. Overview
8.3.2. Prescribed Drugs Market Forecast and Analysis
8.4. OVER THE COUNTER DRUGS
8.4.1. Overview
8.4.2. Over the Counter Drugs Market Forecast and Analysis
9. OPIOID INDUCED CONSTIPATION DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Opioid Induced Constipation Drugs Market Overview
9.1.2 North America Opioid Induced Constipation Drugs Market Forecasts and Analysis
9.1.3 North America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Drug Type
9.1.4 North America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Prescription Type
9.1.5 North America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Opioid Induced Constipation Drugs Market
9.1.5.1.1 United States Opioid Induced Constipation Drugs Market by Drug Type
9.1.5.1.2 United States Opioid Induced Constipation Drugs Market by Prescription Type
9.1.5.2 Canada Opioid Induced Constipation Drugs Market
9.1.5.2.1 Canada Opioid Induced Constipation Drugs Market by Drug Type
9.1.5.2.2 Canada Opioid Induced Constipation Drugs Market by Prescription Type
9.1.5.3 Mexico Opioid Induced Constipation Drugs Market
9.1.5.3.1 Mexico Opioid Induced Constipation Drugs Market by Drug Type
9.1.5.3.2 Mexico Opioid Induced Constipation Drugs Market by Prescription Type
9.2. EUROPE
9.2.1 Europe Opioid Induced Constipation Drugs Market Overview
9.2.2 Europe Opioid Induced Constipation Drugs Market Forecasts and Analysis
9.2.3 Europe Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Prescription Type
9.2.5 Europe Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Opioid Induced Constipation Drugs Market
9.2.5.1.1 Germany Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.1.2 Germany Opioid Induced Constipation Drugs Market by Prescription Type
9.2.5.2 France Opioid Induced Constipation Drugs Market
9.2.5.2.1 France Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.2.2 France Opioid Induced Constipation Drugs Market by Prescription Type
9.2.5.3 Italy Opioid Induced Constipation Drugs Market
9.2.5.3.1 Italy Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.3.2 Italy Opioid Induced Constipation Drugs Market by Prescription Type
9.2.5.4 Spain Opioid Induced Constipation Drugs Market
9.2.5.4.1 Spain Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.4.2 Spain Opioid Induced Constipation Drugs Market by Prescription Type
9.2.5.5 United Kingdom Opioid Induced Constipation Drugs Market
9.2.5.5.1 United Kingdom Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.5.2 United Kingdom Opioid Induced Constipation Drugs Market by Prescription Type
9.2.5.6 Rest of Europe Opioid Induced Constipation Drugs Market
9.2.5.6.1 Rest of Europe Opioid Induced Constipation Drugs Market by Drug Type
9.2.5.6.2 Rest of Europe Opioid Induced Constipation Drugs Market by Prescription Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Opioid Induced Constipation Drugs Market Overview
9.3.2 Asia-Pacific Opioid Induced Constipation Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Prescription Type
9.3.5 Asia-Pacific Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Opioid Induced Constipation Drugs Market
9.3.5.1.1 Australia Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.1.2 Australia Opioid Induced Constipation Drugs Market by Prescription Type
9.3.5.2 China Opioid Induced Constipation Drugs Market
9.3.5.2.1 China Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.2.2 China Opioid Induced Constipation Drugs Market by Prescription Type
9.3.5.3 India Opioid Induced Constipation Drugs Market
9.3.5.3.1 India Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.3.2 India Opioid Induced Constipation Drugs Market by Prescription Type
9.3.5.4 Japan Opioid Induced Constipation Drugs Market
9.3.5.4.1 Japan Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.4.2 Japan Opioid Induced Constipation Drugs Market by Prescription Type
9.3.5.5 South Korea Opioid Induced Constipation Drugs Market
9.3.5.5.1 South Korea Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.5.2 South Korea Opioid Induced Constipation Drugs Market by Prescription Type
9.3.5.6 Rest of Asia-Pacific Opioid Induced Constipation Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Opioid Induced Constipation Drugs Market by Drug Type
9.3.5.6.2 Rest of Asia-Pacific Opioid Induced Constipation Drugs Market by Prescription Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Opioid Induced Constipation Drugs Market Overview
9.4.2 Middle East and Africa Opioid Induced Constipation Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Prescription Type
9.4.5 Middle East and Africa Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Opioid Induced Constipation Drugs Market
9.4.5.1.1 South Africa Opioid Induced Constipation Drugs Market by Drug Type
9.4.5.1.2 South Africa Opioid Induced Constipation Drugs Market by Prescription Type
9.4.5.2 Saudi Arabia Opioid Induced Constipation Drugs Market
9.4.5.2.1 Saudi Arabia Opioid Induced Constipation Drugs Market by Drug Type
9.4.5.2.2 Saudi Arabia Opioid Induced Constipation Drugs Market by Prescription Type
9.4.5.3 U.A.E Opioid Induced Constipation Drugs Market
9.4.5.3.1 U.A.E Opioid Induced Constipation Drugs Market by Drug Type
9.4.5.3.2 U.A.E Opioid Induced Constipation Drugs Market by Prescription Type
9.4.5.4 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa Opioid Induced Constipation Drugs Market by Prescription Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Opioid Induced Constipation Drugs Market Overview
9.5.2 South and Central America Opioid Induced Constipation Drugs Market Forecasts and Analysis
9.5.3 South and Central America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Prescription Type
9.5.5 South and Central America Opioid Induced Constipation Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Opioid Induced Constipation Drugs Market
9.5.5.1.1 Brazil Opioid Induced Constipation Drugs Market by Drug Type
9.5.5.1.2 Brazil Opioid Induced Constipation Drugs Market by Prescription Type
9.5.5.2 Argentina Opioid Induced Constipation Drugs Market
9.5.5.2.1 Argentina Opioid Induced Constipation Drugs Market by Drug Type
9.5.5.2.2 Argentina Opioid Induced Constipation Drugs Market by Prescription Type
9.5.5.3 Rest of South and Central America Opioid Induced Constipation Drugs Market
9.5.5.3.1 Rest of South and Central America Opioid Induced Constipation Drugs Market by Drug Type
9.5.5.3.2 Rest of South and Central America Opioid Induced Constipation Drugs Market by Prescription Type
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL OPIOID INDUCED CONSTIPATION DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. OPIOID INDUCED CONSTIPATION DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA PLC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MALLINCKRODT PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SALIX PHARMACEUTICALS INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SHIONOGI AND CO LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. IRONWOOD PHARMACEUTICAL INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROGENICS PHARMACEUTICALS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NEKTAR THERAPEUTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PURDUE PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca plc.
2. Mallinckrodt Pharmaceuticals
3. Salix Pharmaceuticals Inc.
4. Merck & Co Inc.
5. Shionogi & Co Ltd.
6. Ironwood Pharmaceutical Inc.
7. Pfizer
8. Progenics Pharmaceuticals Inc.
9. Nektar Therapeutics
10. Purdue Pharma
TIPRE00017476
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking